Any provider claiming to offer cagrilintide outside of a clinical trial is not operating within FDA guidelines
Obesity is a complex metabolic disease
A 2019 ultrasound study (Gibney et al., Diabetes Obesity and Metabolism ) measured actual needle-tip placement in 240 subcutaneous injections and found that the "always 45 degrees" rule produced correct placement in only 64% of injections
These results show much clinical promise, as the magnitude of improvement in patients is comparable to the standard of care, acetazolamide
While weekly injections like Wegovy and Zepbound have become the standard for medical weight management, new oral options are emerging that promise similar benefits in pill form
For example, mail-order pharmacy rules, step therapy requirements, or obscure formulary changes can derail an otherwise valid claim